MELANIE J BUTTROSS

Allopathic & Osteopathic Physicians|Ophthalmology WASHINGTON, DC NPI 1023086592

General Payments — all program years on this page

$2,337.06

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 93
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $471.14 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $471.1419

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $115.627
2019 $541.2217
2020 $281.6110
2021 $183.2610
2022 $287.2513
2023 $456.9617
2024 $471.1419

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1110569318 Alcon Vision LLC $19.86 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115473120 Amgen Inc. $17.28 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115473125 Amgen Inc. $32.36 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115473131 Amgen Inc. $26.24 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139086156 Tarsus Pharmaceuticals, Inc. $35.74 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139086158 Tarsus Pharmaceuticals, Inc. $27.23 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139086160 Tarsus Pharmaceuticals, Inc. $33.64 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139086162 Tarsus Pharmaceuticals, Inc. $21.91 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140408656 Bausch & Lomb Americas Inc. $14.73 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140408658 Bausch & Lomb Americas Inc. $23.92 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140408660 Bausch & Lomb Americas Inc. $17.60 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140408662 Bausch & Lomb Americas Inc. $21.97 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147415522 Oyster Point Pharma, Inc. $14.29 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147421112 Oyster Point Pharma, Inc. $21.38 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147437875 Oyster Point Pharma, Inc. $19.40 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152181422 SUN PHARMACEUTICAL INDUSTRIES INC. $30.90 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152181424 SUN PHARMACEUTICAL INDUSTRIES INC. $34.35 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152181426 SUN PHARMACEUTICAL INDUSTRIES INC. $25.57 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152181428 SUN PHARMACEUTICAL INDUSTRIES INC. $32.77 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.